Cargando…
Precision therapy for three Chinese families with maturity-onset diabetes of the young (MODY12)
Maturity-onset diabetes of the young (MODY) is rare monogenic diabetes. However, MODY is often undiagnosed or misdiagnosed. In this study, we aimed to investigate the pathogenic gene for diabetes and provide precise treatment for diabetes patients in three families. Three families with suspected MOD...
Autores principales: | Li, Juyi, Wang, Xiufang, Mao, Huihui, Wen, Li, Deng, Aiping, Li, Yarong, Zhang, Hongmei, Liu, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381955/ https://www.ncbi.nlm.nih.gov/pubmed/35992135 http://dx.doi.org/10.3389/fendo.2022.858096 |
Ejemplares similares
-
Precision Therapy for a Chinese Family With Maturity-Onset Diabetes of the Young
por: Li, Juyi, et al.
Publicado: (2021) -
ABCC8-Related Maturity-Onset Diabetes of the Young (MODY12): A Report of a Chinese Family
por: Lin, Leweihua, et al.
Publicado: (2020) -
Identification and precision therapy for three maturity-onset diabetes of the young (MODY) families caused by mutations in the HNF4A gene
por: Zhang, Juan, et al.
Publicado: (2023) -
Late Diagnosis of Maturity-Onset Diabetes of the Young (MODY) 12 With Catastrophic Consequences
por: Carreira, Nuno R, et al.
Publicado: (2021) -
A Missense Mutation in IRS1 is Associated with the Development of Early-Onset Type 2 Diabetes
por: Li, Juyi, et al.
Publicado: (2020)